For existing injectable users: The convenience factor here is massive
doi: 10.2337/db21-0848 Summary Keywords GLP-1 - glucagon-like peptide-1, GIP - glucose-dependent insulinotropic peptide, obesity, incretin, pharmacology Citation Douros JD, Flak JN and Knerr PJ (2025) The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
The full conversion table is in the reconstitution section
Men on clomiphene citrate reported adverse events (depressive thoughts, weak muscle strength, gynecomastia, mood changes, agitation, or changes in estradiol or hematocrit levels) 18.18% of the time compared to just 3.45% of the time for patients on enclomiphene
Diabetologia 2006,49:930-936
Wu PJ, Chen JB, Lee WC et al (2018) Oxidative stress and nonalcoholic fatty liver disease in hemodialysis patients